Currently, there are 208.17M common shares owned by the public and among those 163.91M shares have been available to trade.
The company’s stock has a 5-day price change of -22.39% and -7.86% over the past three months. ASTS shares are trading 7.77% year to date (YTD), with the 12-month market performance up to 695.10% higher. It has a 12-month low price of $1.97 and touched a high of $39.08 over the same period. ASTS has an average intraday trading volume of 11.72 million shares. The stock is trading above its simple moving averages at the SMA20, SMA50, and SMA200, as the current price level is off by -18.15%, -13.40%, and -2.63% respectively.
Institutional ownership of AST SpaceMobile Inc (NASDAQ: ASTS) shares accounts for 33.24% of the company’s 208.17M shares outstanding.
It has a market capitalization of $7.20B and a beta (3y monthly) value of 1.78. The earnings-per-share (ttm) stands at -$1.96. Price movements for the stock have been influenced by the stock’s volatility, which stands at 6.68% over the week and 10.79% over the month.
Analysts forecast that AST SpaceMobile Inc (ASTS) will achieve an EPS of -0.14 for the current quarter, -0.17 for the next quarter and -0.71 for current fiscal year. The lowest estimate earnings-per-share for the quarter is -0.21 while analysts give the company a high EPS estimate of -0.21. Comparatively, EPS for the current quarter was -0.16 a year ago. Earnings per share for the fiscal year are expected to increase by 53.69%, and 57.11% over the next financial year.
Looking at the support for the ASTS, a number of firms have released research notes about the stock. Cantor Fitzgerald stated their Overweight rating for the stock in a research note on February 06, 2025, with the firm’s price target at $30. UBS coverage for the AST SpaceMobile Inc (ASTS) stock in a research note released on March 08, 2024 offered a Buy rating with a price target of $7. Scotiabank was of a view on March 06, 2024 that the stock is Sector Outperform, while B. Riley Securities gave the stock Buy rating on October 28, 2022, issuing a price target of $15. Barclays on their part issued Overweight rating on July 12, 2021.
